Pennell, D. J., Porter, J. B., Cappellini, M. D., Chan, L. L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.-K., Viprakasit, V., Elalfy, M. S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B. and Taher, A. (2012) “Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major”, Haematologica. Pavia, Italy, 97(6), pp. 842-848. doi: 10.3324/haematol.2011.049957.